Omrix Biopharmaceuticals, Inc.

CIK 1349426 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Omrix Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 17, 2009SC 13G/A0000902664-09-000930
Feb 13, 2009SC 13G/A0001193125-09-029034
Dec 30, 200825-NSE0001354457-08-000360
Dec 30, 2008SC 13D/A0000807249-08-000609
Dec 30, 200815F-12G0001341004-08-003201
Dec 29, 2008SC TO-T/A0000950157-08-001049
Dec 19, 2008SC 14D9/A0001341004-08-003136
Dec 19, 2008SC TO-T/A0000950157-08-001032
Dec 19, 2008SC 14D9/A0001341004-08-003124
Dec 18, 2008SC 13D0000807249-08-000583
Dec 17, 2008SC TO-T/A0000950157-08-001004
Dec 17, 2008SC TO-T/A0000950157-08-001016
Dec 17, 2008SC 14D9/A0001341004-08-003116
Dec 12, 2008SC TO-T/A0000950157-08-000997
Dec 11, 2008SC 14D9/A0001341004-08-003080
Dec 5, 2008SC 14D9/A0001341004-08-003049
Dec 1, 2008SC TO-T/A0000950157-08-000977
Dec 1, 2008SC 14D9/A0000950123-08-016706
Nov 26, 2008SC 14D90000950123-08-016396
Nov 25, 2008SC14D9C0000950123-08-016301
Nov 25, 200840001209191-08-062677
Nov 25, 20088-K0000950123-08-016346
Nov 25, 2008SC TO-T0000950123-08-016356
Nov 24, 2008SC TO-C0000950157-08-000970
Nov 21, 20088-K0000950123-08-015960